3 | SEC Filings Hub

Filing metadata

Accession number: 0001683168-23-000025
Form type: Form 3
Filer: CNS Pharmaceuticals, Inc.
CIK: CIK 1729427
Filed: Jan 04, 2023
Reporting period: Dec 30, 2022
Description: Initial ownership

Documents

0001683168-23-000025-index.htm

Complete submission

0001683168-23-000025.txt

directory listing

Filed by

CNS Pharmaceuticals, Inc.